Biomaterial Database

[Trypsin and C-peptide concentration in the blood serum of patients with chronic pancreatitis]. 1989

E M Starodub

A study of 47 patients suffering of chronic pancreatitis indicates that the phase of exacerbation of the disease first showed changes in the parameters of external secretion while the incretory system of the pancreas, apparently, reveals disorders at a later phase. With the purpose of correction of the hormonal homeostasis it is recommended to use microcrystalline cellulose as an addition to the diet.

UI	MeSH Term	Description	Entries
D008875	Middle Aged	An adult aged 45 - 64 years.	Middle Age
D010195	Pancreatitis	INFLAMMATION of the PANCREAS. Pancreatitis is classified as acute unless there are computed tomographic or endoscopic retrograde cholangiopancreatographic findings of CHRONIC PANCREATITIS (International Symposium on Acute Pancreatitis, Atlanta, 1992). The two most common forms of acute pancreatitis are ALCOHOLIC PANCREATITIS and gallstone pancreatitis.	Acute Edematous Pancreatitis,Acute Pancreatitis,Pancreatic Parenchyma with Edema,Pancreatic Parenchymal Edema,Pancreatitis, Acute,Pancreatitis, Acute Edematous,Peripancreatic Fat Necrosis,Acute Edematous Pancreatitides,Acute Pancreatitides,Edema, Pancreatic Parenchymal,Edematous Pancreatitides, Acute,Edematous Pancreatitis, Acute,Fat Necrosis, Peripancreatic,Necrosis, Peripancreatic Fat,Pancreatic Parenchymal Edemas,Pancreatitides, Acute,Pancreatitides, Acute Edematous,Parenchymal Edema, Pancreatic,Peripancreatic Fat Necroses
D002096	C-Peptide	The middle segment of proinsulin that is between the N-terminal B-chain and the C-terminal A-chain. It is a pancreatic peptide of about 31 residues, depending on the species. Upon proteolytic cleavage of proinsulin, equimolar INSULIN and C-peptide are released. C-peptide immunoassay has been used to assess pancreatic beta cell function in diabetic patients with circulating insulin antibodies or exogenous insulin. Half-life of C-peptide is 30 min, almost 8 times that of insulin.	Proinsulin C-Peptide,C-Peptide, Proinsulin,Connecting Peptide,C Peptide,C Peptide, Proinsulin,Proinsulin C Peptide
D002908	Chronic Disease	Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).	Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D003131	Combined Modality Therapy	The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used.	Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328	Adult	A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available.	Adults
D000368	Aged	A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available.	Elderly
D014357	Trypsin	A serine endopeptidase that is formed from TRYPSINOGEN in the pancreas. It is converted into its active form by ENTEROPEPTIDASE in the small intestine. It catalyzes hydrolysis of the carboxyl group of either arginine or lysine. EC 3.4.21.4.	Tripcellim,Trypure,beta-Trypsin,beta Trypsin

Related Publications

E M Starodub

[Concentration of trypsin and C-peptide in the sera of patients with chronic pancreatitis].

September 1982, Klinicheskaia meditsina,

E M Starodub

[C-peptide in the blood serum of patients with chronic pancreatitis].

January 1980, Polskie Archiwum Medycyny Wewnetrznej,

E M Starodub

The serum concentration of insulin, C-peptide, and proinsulin in patients with acute pancreatitis.

April 1995, International journal of pancreatology : official journal of the International Association of Pancreatology,

E M Starodub

[Serum immunoreactive trypsin in chronic pancreatitis patients].

January 1985, Vutreshni bolesti,

E M Starodub

Increased serum chemerin concentration in patients with chronic pancreatitis.

May 2012, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver,

E M Starodub

Decreased serum leptin concentration in patients with chronic pancreatitis.

May 2007, Pancreas,

E M Starodub

[Possibilities of determination of trypsin in the blood serum of patients with pancreatitis].

September 1973, Vrachebnoe delo,

E M Starodub

Serum immunoreactive trypsin response to secretin injection in patients with chronic pancreatitis.

March 1984, The American journal of gastroenterology,

E M Starodub

[The effect of a protein-rich diet on the trypsin activity in the blood serum of patients with chronic pancreatitis].

January 1967, Voprosy pitaniia,